Dr. Ton Rijnders, public private collaboration

Dr. Ton Rijnders, Scientific Director Top Institute Pharma

Ton Rijnders joined Organon B.V. in 1986 as Research Scientist in the Microbiological R&D Lab. The focus of his work was on development of new treatments for rheumatoid arthritis. In 1992 he became Head of the Department of Immunology. In 1997, the pharmacological research for the therapeutic areas Hormone Replacement, Infertility, Contraception, Immunology and Cardiovascular were combined into one Department of Pharmacology that Ton headed until December 2002. When Organon‘s headquarters moved to the USA, Ton was appointed Vice President Research NV Organon. In 2005 the Toxicology Department was embedded in the Oss research organization. In 2006 Ton was appointed Senior VP Research and this responsibilities were further broadened with the inclusion of the Toxicology and Process Chemistry Departments in Riom (France). After the acquisition of Organon by Schering-Plough in 2007, Ton was appointed VP Discovery and Site Head Oss within the Schering-Plough Research Institute. Ton was also the local lead for the combined SPRI functions in The Netherlands and as such member of the local site management. He continued to head Discovery in Oss within the Merck Research Labs after the merger of Merck with Schering-Plough, while also maintaining local responsibility for the entire MRL Oss organization. In fall 2011, Ton was appointed Scientific Director of Top-Institute-Pharma (TIP), a public private partnership in drug discovery.

Ton Rijnders is member of several scientific and professional societies. He is also a member of the supervisory board of the Netherlands Metabolomics Centre, the Netherlands consortium for Systems Biology and the Netherlands BioInformatics Centre, which are consortia of the Netherlands Genomics Initiative.
Ton Rijnders; wetenschappelijke directeur van Top Institute Pharma.